ARYX (ARYx Therapeutics) OCF Margin %: 0.00% (As of Sep. 2010)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is ARYx Therapeutics OCF Margin %?

ARYx Therapeutics ARYX -99.80% OCF Margin % is 0.00% as of Sep. 2010.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. ARYx Therapeutics's Cash Flow from Operations for the three months ended in Sep. 2010 was $-4.05 Mil. ARYx Therapeutics's Revenue for the three months ended in Sep. 2010 was $0.00 Mil. Therefore, ARYx Therapeutics's OCF Margin % for the quarter that ended in Sep. 2010 was 0.00%.

As of today, ARYx Therapeutics's current OCF Yield % is 0.00%.

The historical rank and industry rank for ARYx Therapeutics's OCF Margin % or its related term are showing as below:


ARYX's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.8
* Ranked among companies with meaningful OCF Margin % only.

ARYx Therapeutics OCF Margin % Related Terms

ARYx Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for ARYx Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ARYx Therapeutics OCF Margin % Chart

ARYx Therapeutics Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09
OCF Margin %
Get a 7-Day Free Trial 0.00 -88.90 -666.31 -229.25 0.00

ARYx Therapeutics Quarterly Data
Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ARYx Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

ARYx Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2009 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2009 )/Revenue (A: Dec. 2009 )
=-34.967/0
= %

ARYx Therapeutics's OCF Margin for the quarter that ended in Sep. 2010 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2010 )/Revenue (Q: Sep. 2010 )
=-4.046/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
ARYx Therapeutics (ARYX) has a OCF Margin % of 0.00% as of Sep. 2010. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ARYx Therapeutics and its competitors.
Is ARYx Therapeutics' OCF Margin % too high?
ARYx Therapeutics' current OCF Margin % is 0.00%.
How does ARYx Therapeutics' OCF Margin % compare to YBAO and HPMM?
ARYx Therapeutics' OCF Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median OCF Margin % is 9.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.80, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ARYx Therapeutics and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ARYx Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ARYx Therapeutics stock overvalued right now?
ARYx Therapeutics (ARYX) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For ARYx Therapeutics (ARYX), the current OCF Margin % is 0.00% as of Sep. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ARYx Therapeutics Business Description

Address 6300 Dumbarton Circle, Fremont, CA, USA, 94555
ARYx Therapeutics Inc is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs.